Trials / Active Not Recruiting
Active Not RecruitingNCT05327127
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Participants With Noncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 228 (actual)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-877-ER | K-877-ER tablet |
| DRUG | CSG452 | CSG452 tablet |
| DRUG | Placebo | Placebo tablet |
Timeline
- Start date
- 2022-11-14
- Primary completion
- 2026-05-05
- Completion
- 2026-06-02
- First posted
- 2022-04-14
- Last updated
- 2026-03-27
Locations
77 sites across 6 countries: United States, Argentina, Brazil, Canada, Japan, Spain
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05327127. Inclusion in this directory is not an endorsement.